Palantir wins $44 million FDA contract, boosting shares 21%

tagreuterscom2020binary_lynxmpegb61kw-viewimagetokenukfrhuv30flhjh4kbdobpwm6axp1ykdj81kix5wuiti_savahlq.JPEG


By Carl O’Donnell
(Reuters) – Data analytics company Palantir Technologies Inc was awarded a $44.4 million contract by the U.S. Food and Drug Administration, a Palantir spokeswoman said, sending its shares up around 21%.
Bloomberg first reported the deal.
The three-year contract covers data and analytics services to the FDA’s Center for Drug Evaluation and Research (CDER) to speed its review of potential new medicines. It is one of dozens that Palantir has with the U.S. government.
The contract also provides services to the FDA’s Oncology Center of Excellence, which helps with the development and review of cancer products.
Palantir also provides data analytics for the U.S. Army, and the National Institutes …

Read More on Datafloq
Credit: Source link